Genes in MS Patients Westbury NY

Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports. "Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release.

Local Companies

Janet Jean Shen
(516) 562-0100
300 Community Dr
Manhasset, NY
Steven Tillem
(718) 932-3535
3601 31St Ave
Long Island City, NY
Kristie Nornick
(516) 663-0333
259 1St St
Mineola, NY
Steven Kellner
(516) 569-2250
571 Chestnut St
Cedarhurst, NY
Robert Johnson
(631) 724-2000
267 East Main Street Suite 100
Smithtown, NY
Annamma Zachariah
(718) 579-6720
1932 Arthur Ave Tremont Child Health
Bronx, NY
Garry Stark
(516) 355-7516
2035 Lakeville Rd # 3
New Hyde Park, NY
Giovanni Marciano
(718) 805-0037
8616 Jamaica Ave
Jamaica, NY
Jonathan Goldstein
(516) 663-2522
259 1St St
Mineola, NY
Mark Perelman
(516) 432-0621
58 Illinois Ave
Long Beach, NY
Data Provided by:
  

Provided By:

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.

SOURCE: Mayo clinic, news release, Sept. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Genetic Clues for Skin Cancer Therapies Westbury NY
Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.
- Doctor-Patient Talk for Hypertension Westbury NY
- Exercise for Chemotherapy Patients Westbury NY
- Hospice: Getting Back Control of Your Life Westbury NY
- Depression in Heart Disease Patients Westbury NY
- High Blood Pressure Genes Westbury NY
- Gene Therapy for Parkinson's Westbury NY
- Side Effect Of Chemotherapy Drugs Westbury NY
- Gene Variants and Alzheimer's Risk Westbury NY
- Differences Between Hospice and Palliative Care Westbury NY